Literature DB >> 26748087

Common Brain Mechanisms of Chronic Pain and Addiction.

Igor Elman1, David Borsook2.   

Abstract

While chronic pain is considered by some to be a CNS disease, little is understood about underlying neurobiological mechanisms. Addiction models have heuristic value in this regard, because both pain and addictive disorders are characterized by impaired hedonic capacity, compulsive drug seeking, and high stress. In drug addiction such symptomatology has been attributed to reward deficiency, impaired inhibitory control, incentive sensitization, aberrant learning, and anti-reward allostatic neuroadaptations. Here we propose that similar neuroadaptations exist in chronic pain patients.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  amygdala; analgesia; catastrophizing; corticotropin-releasing factor; deficient or excessive reward dysfunction; delay discounting; dopamine; dynorphin; effectors; habenula; hedonostat; homeostasis; nucleus accumbens; opioid; opponent; prediction error; regulators; therapeutic dependence

Mesh:

Year:  2016        PMID: 26748087     DOI: 10.1016/j.neuron.2015.11.027

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  96 in total

1.  Psychosocial Predictors of Acute and Chronic Pain in Adolescents Undergoing Major Musculoskeletal Surgery.

Authors:  Jennifer A Rabbitts; Tonya M Palermo; Chuan Zhou; Alagumeena Meyyappan; Lucas Chen
Journal:  J Pain       Date:  2020-06-15       Impact factor: 5.820

Review 2.  Cortico-limbic pain mechanisms.

Authors:  Jeremy M Thompson; Volker Neugebauer
Journal:  Neurosci Lett       Date:  2018-11-29       Impact factor: 3.046

3.  Intact responses to non-drug rewards in long-term opioid maintenance treatment.

Authors:  Marie Eikemo; Philipp P Lobmaier; Mads L Pedersen; Nikolaj Kunøe; Anna Maria Matziorinis; Siri Leknes; Monica Sarfi
Journal:  Neuropsychopharmacology       Date:  2019-03-31       Impact factor: 7.853

4.  Hypothesizing That Neuropharmacological and Neuroimaging Studies of Glutaminergic-Dopaminergic Optimization Complex (KB220Z) Are Associated With "Dopamine Homeostasis" in Reward Deficiency Syndrome (RDS).

Authors:  Kenneth Blum; Marcelo Febo; Lyle Fried; Mona Li; Kristina Dushaj; Eric R Braverman; Thomas McLaughlin; Bruce Steinberg; Rajendra D Badgaiyan
Journal:  Subst Use Misuse       Date:  2016-12-29       Impact factor: 2.164

Review 5.  Corticolimbic circuitry in the modulation of chronic pain and substance abuse.

Authors:  Anna M W Taylor
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2017-05-10       Impact factor: 5.067

6.  Mindfulness is Associated With Increased Hedonic Capacity Among Chronic Pain Patients Receiving Extended Opioid Pharmacotherapy.

Authors:  Elizabeth A Thomas; Eric L Garland
Journal:  Clin J Pain       Date:  2017-02       Impact factor: 3.442

7.  Impaired frontostriatal functional connectivity among chronic opioid using pain patients is associated with dysregulated affect.

Authors:  Patrick A McConnell; Eric L Garland; Jon-Kar Zubieta; Roger Newman-Norlund; Shannon Powers; Brett Froeliger
Journal:  Addict Biol       Date:  2019-04-04       Impact factor: 4.280

8.  Pharmacological mechanisms of alcohol analgesic-like properties in mouse models of acute and chronic pain.

Authors:  Bradley Neddenriep; Deniz Bagdas; Katherine M Contreras; Joseph W Ditre; Jennifer T Wolstenholme; Michael F Miles; M Imad Damaj
Journal:  Neuropharmacology       Date:  2019-09-25       Impact factor: 5.250

9.  Withdrawal-associated injury site pain prevalence and correlates among opioid-using people who inject drugs in Vancouver, Canada.

Authors:  Launette Marie Rieb; Kora DeBeck; Kanna Hayashi; Evan Wood; Ekaterina Nosova; M-J Milloy
Journal:  Drug Alcohol Depend       Date:  2020-08-18       Impact factor: 4.492

10.  Pain intensity, e-cigarette dependence, and cessation-related outcomes: The moderating role of pain-related anxiety.

Authors:  Jessica M Powers; Lisa R LaRowe; Lorra Garey; Michael J Zvolensky; Joseph W Ditre
Journal:  Addict Behav       Date:  2020-07-11       Impact factor: 3.913

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.